.Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AR05_ZidovudineLamivudineAndNevirapin.ZidovudineLamivudineAndNevirapin

Information

Zidovudine, lamivudine, and nevirapine is a fixed-dose combination antiretroviral medication used for the treatment of HIV infection. It combines two nucleoside reverse transcriptase inhibitors (zidovudine and lamivudine) with a non-nucleoside reverse transcriptase inhibitor (nevirapine). This combination is approved and in use worldwide, especially in resource-limited settings as a first-line therapy.

Pharmacokinetics

Pharmacokinetic parameters in HIV-infected adults under steady-state conditions with oral administration of the fixed-dose combination tablet.

References

Revisions

• 06/2025 initial generated model